Patients with known human immunodeficiency virus (HIV) seropositive are not eligible
Patients known to be seropositive for human immunodeficiency virus (HIV) and active hepatitis, even if liver function studies are in the eligible range
Known to be seropositive for human immunodeficiency virus;
Subject is known to be seropositive for, or have an active infection with, human immunodeficiency virus (HIV).
Patients seropositive for the human immunodeficiency virus (HIV).
Seropositive for the human immunodeficiency virus (HIV).
Patients who are human immunodeficiency virus (HIV) seropositive
Patients seropositive for the human immunodeficiency virus (HIV).
Patients who are (human immunodeficiency virus [HIV]) seropositive
Known human immunodeficiency virus (HIV) seropositive
Patients who are human immunodeficiency virus (HIV) seropositive
Has known human immunodeficiency virus (HIV) seropositive.
Patients who are known to be seropositive for human immunodeficiency virus (HIV)
Human immunodeficiency virus (HIV) seropositive, or active hepatitis A, B, or C infection
Known history of human immunodeficiency virus (HIV) seropositive status
Know to be seropositive for human immunodeficiency virus (HIV)
Known human immunodeficiency virus (HIV) seropositive
Persons who are seropositive for human immunodeficiency virus (HIV)
Patients who are human immunodeficiency virus (HIV) seropositive
Patient is human immunodeficiency virus seropositive.
Seropositive for human immunodeficiency virus (HIV)
HIV-1 seropositive
Known to be human immunodeficiency virus (HIV) seropositive
Patients seropositive for the human immunodeficiency virus (HIV)
Known history of human immunodeficiency virus (HIV) seropositive status
Known to be seropositive for human immunodeficiency virus (HIV); an HIV test is not required for entry on this protocol, but is required if the patient is perceived to be at risk
Patients who are known to be human immunodeficiency virus (HIV)-seropositive
Human immunodeficiency virus (HIV) seropositive; testing for HIV should be within 6 months of enrollment
Seropositive for the human immunodeficiency virus
Known seropositive for HIV
Known to be human immunodeficiency virus (HIV) seropositive
Patients seropositive for the human immunodeficiency virus (HIV).
HIV-1 seropositive
Seropositive for human immunodeficiency virus (HIV)
HIV-1 seropositive at or before the time of lymphoma diagnosis
Human immunodeficiency virus (HIV) seropositive
Patients known to be seropositive for human immunodeficiency virus (HIV) and active hepatitis, even if liver function studies are in the eligible range
Known seropositive for or active viral infection with human immunodeficiency virus (HIV).
Known human immunodeficiency virus (HIV) seropositive.
Known history of human immunodeficiency virus (HIV) seropositive status
Patients who are known to be seropositive for human immunodeficiency virus (HIV)
Patients seropositive for the human immunodeficiency virus (HIV)
Known to be seropositive for human immunodeficiency virus (HIV)
Known to be human immunodeficiency virus (HIV) seropositive
Known to be human immunodeficiency virus (HIV) seropositive who are on anti-HIV drugs
Known to be human immunodeficiency virus (HIV) seropositive
Known seropositive for human immunodeficiency virus (HIV)
Known seropositive for or active viral infection with human immunodeficiency virus (HIV)
Patients who are known to be seropositive for human immunodeficiency virus (HIV)
Patients known to be seropositive for human immunodeficiency virus (HIV) and/or active hepatitis, even if liver function studies are in the eligible range
Known history of human immunodeficiency virus (HIV) seropositive status
Human immunodeficiency virus (HIV) seropositive patients
Patients who are known seropositive for human immunodeficiency virus (HIV)
Seropositive for the human immunodeficiency virus (HIV)
Known or suspected human immunodeficiency virus (HIV) infection or patients who are HIV seropositive;
Human immunodeficiency virus (HIV) seropositive
Patients who are known seropositive for or who have active viral infection with human immunodeficiency virus (HIV) are not eligible
Known history of a human immunodeficiency virus (HIV) seropositive test
Known to be human immunodeficiency virus (HIV) seropositive
Known human immunodeficiency virus (HIV)-seropositive and are taking anti-retrovirals may not participate in this study; participants who are HIV-seropositive and not on anti-retroviral therapy and who otherwise meet the inclusion/exclusion criteria will be eligible for the study
Seropositive for the human immunodeficiency virus (HIV)
Known to be human immunodeficiency virus (HIV) seropositive
Patients who are seropositive for human immunodeficiency virus (HIV)
Known seropositive for human immunodeficiency virus (HIV); HIV testing is not required; hepatitis testing is not required
Seropositive for human immunodeficiency virus (HIV).
Seropositive for human immunodeficiency virus (HIV).
Subjects known to be seropositive for HIV or for HTLV-I
Patients seropositive for HIV-1 or -2
Patients seropositive for the human immunodeficiency virus (HIV)
Patients who are seropositive for human immunodeficiency virus (HIV)
Patients who are human immunodeficiency virus (HIV) seropositive
Patients seropositive for the human immunodeficiency virus (HIV)
Patients seropositive for the human immunodeficiency virus (HIV)
Positive human immunodeficiency virus (HIV) or human T-cell lymphotrophic virus (HTLV)-1 serology
Negative human T-lymphotropic virus (HTLV)-1 and 2 antibodies.
EXCLUSION - PROCUREMENT: Active infection with human immunodeficiency virus (HIV) or human T-lymphotropic virus (HTLV)
PROCUREMENT EXCLUSION: Active infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus (HTLV) (can be pending at this time)
No known history of human immunodeficiency virus (HIV) 1 and 2, human T-cell lymphotropic virus (HTLV)-I/II, and hepatitis B and C
PART I: Negative serology for anti-human immunodeficiency virus (HIV)-1/2 and anti-human T-lymphotropic virus (HTLV) 1/2
Patients must have serum antibodies directed to human T-cell lymphotropic virus (HTLV)-1
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1)
Seropositivity for human T-lymphotropic virus type 1 (HTLV-1).
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1)
Donors who are human immunodeficiency virus (HIV)-1, HIV-2, human T-lymphotropic virus (HTLV)-1, HTLV-2 seropositive or with active hepatitis B or hepatitis C virus infection
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1) seropositive status
Known infection with Human Immunodeficiency Virus (HIV) or Human T-lymphotropic Virus 1 (HTLV-1).
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1) seropositive status
Seronegative for human T-cell lymphotropic virus type 1 (HTLV-1)
Positive results for the human T-lymphotrophic 1 virus (HTLV-1)
Patients with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1) are not eligible
Subject has positive test result at the screening visit for one or more of the following:\r\n* Human T-cell lymphotropic virus (HTLV-1/2)\r\n* Anti-human immunodeficiency virus (HIV) 1 antibody (alpha-HIV-1)
EXCLUSION CRITERIA FOR ENROLLMENT: Human immunodeficiency virus (HIV)-1/2 or human T-cell lymphotropic virus (HTLV)-1/2 positivity
Human immunodeficiency virus (HIV) or human T-cell leukemia virus type (HTLV)1/HTLV2 (seropositivity and/or polymerase chain reaction [PCR] positivity)
Active symptomatic fungal, bacterial and/or viral infection including evidence of infection with human immunodeficiency virus (HIV), human T-cell leukemia virus 1 (HTLV-1) seropositive status
Subject has positive test result at the screening visit for one or more of the following: human T-lymphotropic virus (HTLV)-1/2 and/or anti-human immunodeficiency virus (HIV) 1 antibody (alpha-HIV-1)
Known history of infection with human immunodeficiency virus (HIV) or human T cell leukemia virus 1 (HTLV-1)
Active infection with human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV)
History of positive serology tests for human immunodeficiency virus (HIV) 1 and 2, human T cell lymphotropic virus (HTLV)-1, hepatitis B and C
DONOR: HIV or human T-lymphotropic virus (HTLV) seropositive
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV)-I/II
Active infection with human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV), human T-cell lymphotropic virus (HBV), hepatitis C virus (HCV) (can be pending at this time)
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human t-lymphotrophic virus (HTLV) -I/II
Seropositivity for human T-lymphotropic virus type 1 (HTLV-1)
Human immunodeficiency virus (HIV)-1/HIV-2 or human T-lymphotropic virus (HTLV)-1/HTLV-2 seropositivity
Patients with evidence of human immunodeficiency virus (HIV) seropositivity and/or positive polymerase chain reaction (PCR) assay, human T-cell leukemia virus type (HTLV)1/HTLV2 seropositivity
Known human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV) infection
Participants with known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1)
Participants with known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus-1 (HTLV-1)
Patient is positive for human immunodeficiency virus (HIV) or human T-cell lymphotropic virus-1 (HTLV-1)
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV)-I/II
Active infections including human T-lymphotropic virus (HTLV) 1 and 2, and human immunodeficiency virus (HIV) 1 and 2
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-lymphotrophic virus (HTLV)-I/II
Seronegativity for human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV1), hepatitis
Human T-lymphotropic virus (HTLV)-1/2
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV) -I/II
Positive test results for human T-lymphotropic virus type I (HTLV 1) virus in endemic countries
DONOR: Human immunodeficiency virus (HIV) or human T-lymphotrophic virus (HTLV) infection
Known human immunodeficiency virus (HIV) or human T-lymphotropic virus, type I (HTLV-I) positive status
Human immunodeficiency virus (HIV) or Human T Cell Lymphotropic Virus 1 (HTLV-1) infection
Human immunodeficiency virus (HIV) or human T-lymphotropic virus (HTLV)-I/II
Human immunodeficiency virus (HIV) infection or Human T Cell Lymphotropic Virus 1 (HTLV-1) infection
Has a known human T-lymphotropic virus type 1 (HTLV) infection
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1)
Known infection with human immunodeficiency virus (HIV) or Human T-Cell Leukemia Virus 1 (HTLV-1) seropositive status
Known history of human immunodeficiency virus (HIV) seropositive status or known infection with human T-cell leukemia virus 1 (HTLV-1) virus
No known history of human immunodeficiency virus (HIV) 1/2, human T-lymphotropic virus (HTLV)-I/II
Patients seropositive for Human T-Lymphotrophic Virus (HTLV)-I or -II
Positive serology for human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV) at any time prior to enrollment;
The patient has known positive human immunodeficiency virus (HIV) or known active human t-cell lymphotropic virus (HTLV) I/II disease, whether on treatment or not.